PlainPill

Kava

The short answer. More people than not who report on Kava say it helped (63% of 224). It is most often used for anxiety: 93% of 196 reports say that improved. It is well studied — 41 meta-analyses on PubMed. The most common complaint is drowsiness.

What users report
63%helped224 reports · high confidence
142 helped56 mixed26 didn't help

From 431 mentions in total — the rest didn't say how it went and aren't counted.

Clinical research
AStrong research base
41
meta-analyses
37
RCTs
815
papers

What Kava does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 41 meta-analyses on PubMed ↗ · 37 randomized trials ↗

BMC Psychiatry · 2020 · Meta-analysis / systematic review
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

Conclusion: There is currently encouraging, albeit embryonic, evidence for medicinal cannabis in the treatment of a range of psychiatric disorders. Supportive findings are emerging for some key isolates, however, clinicians need to be mindful of a range of prescriptive and occupational safety considerations, especially if initiating higher dose THC formulas.

PubMed 31948424 ↗
World J Biol Psychiatry · 2022 · Meta-analysis / systematic review
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

Conclusion: Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders. However several had only a weak endorsement for potential use; for a few it was not possible to reach a clear recommendation direction, largely due to mixed study findings; while some other agents showed no obvious therapeutic benefit and were clearly not recommended for use. It is the intention of these guidelines to inform psychiatric/medical, and health professional practice

PubMed 35311615 ↗
Registered clinical trials

18 human trials on ClinicalTrials.gov test Kava — 7 completed, 3 recruiting now. See all on ClinicalTrials.gov ↗

Reports to the FDA

Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.

58 reports name a product containing Kava (2004–2026); 32 involved hospitalization or worse. Most often reported:

  • Nausea · 18
  • Dependence · 10
  • Fatigue · 9
  • Vomiting · 9
  • Diarrhoea · 8
  • Rash · 5

A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.

What government agencies say

Official records from US, Canadian and EU regulators, each linked to its source.

US legal status (DEA)

Not a scheduled substance, but the DEA lists Kava as a drug of concern. DEA fact sheet ↗

FDA recalls

7 recalls of products named for Kava. Most recent:

  • 2023-12-20 · Class II: Finished product contains kratom (an unapproved food additive) and pH is over 5.0. The process authority letter classified product as acidified and pH… record ↗
  • 2022-06-29 · Class II: The microbial test result is found to be out of specification due to high yeast and mold counts. record ↗
  • 2016-05-11 · Class III: Pursuant to a consent decree for injunctive relief the recalling firm was ordered to recall all products because they are misbranded, unapproved new drugs… record ↗

Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗

Liver safety (LiverTox, NIH)

LiverTox rates Kava A — a well-established cause of liver injury (more than 50 published cases). LiverTox entry ↗

Safety (NCCIH, NIH)

“Various kava products have been linked to rare cases of liver injury, some of which have been serious or even fatal. The first reported cases involved medicinal or dietary supplement products that had been extracted with alcohol or acetone, but other cases have involved kava beverages prepared with water.” NCCIH ↗

European Medicines Agency (herbal)

The EMA reviewed Kava-kava and did not issue a monograph (public statement). EMA ↗

US government research funding (NIH)

NIH has funded 6 research projects with Kava in the title, $3,135,823 in total (2000–2026). NIH RePORTER ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

60 mg kavalactone equivalentdaily
5-6 capsulesas reported
2-3 tabletsas reported
200 mgafternoon
250mgas reported

Reported side effects

How often each side effect came up across all reports.

drowsiness ×7liver damage ×6stomach issues ×3irritability ×3nausea ×2skin cracking ×2bleeding ×2liver toxicity ×2

What users say

First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.

“I felt insanely relaxed, any anxiety was dropped to 0, and I could think more clearly.”
HelpedRead the discussion ↗
“Kava has a definite affect on me, but didn’t budge any of my sleep scores.”
MixedRead the discussion ↗
“The only stuff I actually FEEL are anxiolytics (eg kava) or stimulants (eg caffeine, nicotine and stronger stuff.)”
HelpedRead the discussion ↗
“I use it once or twice a week, and I feel that it really helps alleviate my anxiety.”
HelpedRead the discussion ↗
Read more Kava reviews →
Top discussions (5)

Kava compared

Other options for anxiety

Sources

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate